Does Oscar Health Cover Cialis?

What Cialis Actually Is and Why Coverage Gets Complicated

Cialis is the brand name for tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor approved by the FDA in 2003 for erectile dysfunction and later in 2011 for benign prostatic hyperplasia (BPH). Tadalafil's long half-life of approximately 17.5 hours distinguishes it from sildenafil (Viagra) and allows once-daily low-dose dosing at 5 mg. The drug went off-patent in 2018, making generic tadalafil widely available at a fraction of the brand price.

Insurance coverage for PDE5 inhibitors has long been inconsistent. The core tension: the FDA approves tadalafil for two distinct indications, erectile dysfunction and BPH, and insurers treat those indications differently. BPH is considered a medical condition with clear physiological consequences, while erectile dysfunction coverage is frequently classified as a "lifestyle" benefit subject to plan-specific restrictions or explicit exclusions.

FDA-Approved Indications for Tadalafil

Tadalafil carries three distinct FDA approvals: 10 mg or 20 mg as-needed for ED, 2.5 mg or 5 mg once-daily for ED, and 5 mg once-daily for BPH. The FDA also approved the combination indication of BPH plus ED at 5 mg daily. These distinctions matter because prior authorization requirements and formulary placement often differ by indication code submitted on the prescription.

Why Generic vs. Brand Matters for Your Wallet

Brand-name Cialis can cost $400 to $450 per month at retail. Generic tadalafil from major pharmacy chains runs $10 to $30 for a 30-count supply of 5 mg or 20 mg tablets, a price point so low that even uninsured patients often pay less than their insurance copay would be. FDA generic drug approval records confirm multiple manufacturers hold approved ANDAs for tadalafil, ensuring a competitive generic market.

How Oscar Health's Formulary System Works

Oscar Health operates as an ACA marketplace insurer with commercial plans across more than 20 states. Like most insurers, Oscar uses a tiered formulary structure that determines how much you pay for a covered drug.

Oscar's Tier Structure

Oscar plans typically use a four-to-five-tier formulary:

• Tier 1: Preferred generics (lowest copay, often $0, $10)
• Tier 2: Non-preferred generics and some preferred brands ($15, $40 copay)
• Tier 3: Preferred brands ($40, $70 copay)
• Tier 4: Non-preferred brands ($70, $100+ copay or coinsurance)
• Tier 5 (specialty): High-cost specialty drugs

Generic tadalafil most commonly appears at Tier 2 on Oscar commercial plans. Brand Cialis, where it appears at all, typically lands at Tier 3 or Tier 4. The ACA requires that plans cover essential health benefits, but sexual dysfunction medications do not fall within the ten essential health benefit categories, giving insurers legal latitude to exclude or restrict them.

How to Check Your Specific Oscar Plan's Formulary

Oscar publishes its drug formularies on its member portal and at oscar.com. To verify coverage:

1. Log into your Oscar member account.
2. Manage to "My Benefits" and select "Prescription Coverage."
3. Search for "tadalafil" (generic) and "Cialis" (brand) separately.
4. Note the tier, any quantity limits, and whether prior authorization applies.

Formularies change on January 1 each year. A drug covered last year may carry new restrictions this year. Confirming before your prescription is filled avoids unexpected out-of-pocket charges.

Prior Authorization for Cialis Through Oscar Health

Prior authorization (PA) is the most common obstacle members face. Oscar may require PA for tadalafil prescribed for erectile dysfunction even when the drug appears on the formulary.

What Triggers a Prior Authorization Request

PA is most often triggered when:

• The prescribed indication is erectile dysfunction rather than BPH.
• The quantity exceeds plan limits (e.g., more than 6 tablets per 30 days for as-needed dosing).
• The prescribing provider has not documented a clinical diagnosis in the submitted paperwork.
• A step-therapy requirement exists and no prior PDE5 inhibitor trial is documented.

CMS guidance on step therapy in Medicare Advantage plans provides a regulatory framework that many commercial insurers, including Oscar, voluntarily mirror in their PA policies.

What Your Doctor Needs to Submit

A complete PA request for tadalafil typically requires:

• ICD-10 diagnosis code (N52.9 for erectile dysfunction, N40.1 for BPH with lower urinary tract symptoms)
• Documentation of the clinical evaluation, including history and physical
• Any prior treatments tried and their outcomes
• Testosterone levels if hypogonadism is suspected as a contributing factor
• For BPH: uroflow or symptom scores such as the International Prostate Symptom Score (IPSS)

The AUA guideline on erectile dysfunction recommends that clinicians assess cardiovascular risk before prescribing PDE5 inhibitors, a step that simultaneously generates the documentation Oscar's PA reviewers require.

Timeline and What to Expect

Under federal rules, non-urgent PA decisions must be issued within 72 hours of receiving a complete request. Urgent requests require a response within 24 hours. CMS final rules effective January 1, 2026 will require most payers to process standard PA decisions within 7 calendar days and expedited decisions within 72 hours, with electronic decision notifications. If Oscar's PA team requests additional clinical information, your prescriber typically has 14 days to respond before the request expires.

Step Therapy: When Oscar Requires You to Try Something Else First

Some Oscar plan variants include a step-therapy requirement for PDE5 inhibitors. Step therapy means you must try and fail (or have a contraindication to) a lower-cost alternative before the plan covers the requested drug.

Common Step-Therapy Requirements

For erectile dysfunction, step therapy might require a trial of sildenafil (generic Viagra) before tadalafil is covered. Sildenafil generics often sit at Tier 1, making them less expensive for the insurer. If sildenafil is ineffective or causes side effects you cannot tolerate, your doctor can document that as the basis for advancing to tadalafil.

A 2018 JAMA Internal Medicine analysis found that step-therapy policies affect a substantial proportion of commercially insured patients seeking specialty and brand-name medications, and that incomplete documentation is the most common reason step-therapy exceptions are denied on first submission.

Documenting a Step-Therapy Exception

Your provider should note the following explicitly in the exception request:

• The specific adverse effect or inadequate response to the required first-step drug
• Duration of the trial (typically 4 weeks minimum is expected)
• Any contraindication to the alternative drug, such as a drug-drug interaction with nitrates

FDA labeling for tadalafil includes an absolute contraindication with nitrates and nitric oxide donors, which applies equally to sildenafil. If a patient is on long-acting nitrates for cardiovascular disease, the step-therapy requirement is clinically moot and the exception should be straightforward.

What Happens If Oscar Denies Coverage

A denial is not the end. Federal law gives you the right to appeal, and roughly 40 to 60 percent of PA denials are reversed on first internal appeal when clinical documentation is complete.

Internal Appeal Process

Oscar must provide a written denial with the specific reason and the clinical criteria used to make the decision. Your appeal should directly address each stated reason. Submit:

• A letter of medical necessity from your prescribing provider
• Relevant lab work (testosterone, PSA, metabolic panel)
• Office visit notes documenting the clinical evaluation
• Published guideline citations supporting the treatment choice

The AHA/ACC cardiovascular risk guidelines are useful supporting documents when arguing medical necessity for PDE5 inhibitor therapy, because they frame ED as a marker of cardiovascular risk warranting treatment.

External Appeal

If the internal appeal fails, you have the right to an independent external review. Under the ACA, all non-grandfathered plans must provide access to an independent review organization (IRO). HHS guidance on external appeals requires the IRO's decision to be binding on the plan.

State-Specific Protections

Several states have enacted laws requiring insurers to cover erectile dysfunction treatments without excessive restrictions. New York, for example, passed legislation mandating ED medication coverage on commercial plans. Oscar operates in New York and must comply with state mandates that exceed federal minimums. Check your state's insurance commissioner website for current mandate details.

The BPH Angle: A Different Coverage Path

If your prescription for tadalafil 5 mg daily is for BPH rather than erectile dysfunction, coverage is often easier to obtain. BPH is unambiguously classified as a medical condition.

Clinical Criteria for BPH Coverage

Oscar and most commercial insurers generally require:

• A diagnosis of BPH confirmed on clinical exam or imaging
• An IPSS score of 8 or higher (moderate to severe symptoms)
• A trial of an alpha-blocker such as tamsulosin, unless contraindicated

The AUA BPH guideline recommends tadalafil 5 mg daily as an approved monotherapy option for men with BPH and lower urinary tract symptoms (LUTS), giving your provider strong guideline support for the prescription.

Combination Indication

For men who have both BPH and erectile dysfunction, the FDA-approved combination indication (5 mg tadalafil daily for both conditions simultaneously) can be documented on the prescription. This framing often allows the BPH coverage pathway to carry the claim even if ED alone would trigger more restrictions. Your prescriber should note both ICD-10 codes on the prescription: N40.1 and N52.9.

Cost Alternatives When Coverage Is Denied or Limited

Even without insurance coverage, several options make tadalafil accessible.

Generic Tadalafil Pricing

GoodRx and similar discount programs commonly price 30 tablets of tadalafil 5 mg at $10 to $25 at major chain pharmacies. FDA consumer guidance on generic drugs confirms that generics must be bioequivalent to the brand product, delivering the same clinical effect at a fraction of the cost.

Manufacturer Assistance

Eli Lilly, the maker of brand Cialis, offers a patient assistance program for eligible uninsured patients. Income thresholds apply. Details are available at Lilly Cares Foundation.

Telehealth and Compounding Considerations

Several telehealth platforms prescribe generic tadalafil directly, sometimes for as low as $2 per dose through cash-pay pharmacy partnerships. HealthRX's clinical team can evaluate and prescribe tadalafil as part of a complete sexual health assessment.

The following decision framework summarizes how HealthRX clinicians approach the Oscar Health coverage question for a new patient requesting tadalafil:

Step 1. Confirm the primary indication: BPH, ED, or both. Document with appropriate ICD-10 codes.

Step 2. Check the current-year Oscar formulary for the patient's specific plan ID. Note tier and PA requirements.

Step 3. If PA is required, submit a complete PA packet on day one: office notes, labs, IPSS score if applicable, prior treatment history.

Step 4. If step therapy applies and sildenafil is appropriate, offer a 4-week trial with explicit instructions to report adverse effects or inadequate response.

Step 5. If denied, file the internal appeal within Oscar's stated deadline (usually 180 days from denial). Attach guideline citations directly.

Step 6. If internal appeal fails, file for external review within 4 months of the internal denial.

Step 7. While the appeal is pending, use a GoodRx coupon for generic tadalafil to avoid treatment gaps.

Testosterone's Role: When ED Has a Hormonal Root

Erectile dysfunction in men under 50 frequently has a hormonal component. A 2019 NEJM review of hypogonadism noted that low testosterone is associated with diminished response to PDE5 inhibitors, and that correcting testosterone deficiency with TRT can restore PDE5 inhibitor efficacy in men who had previously experienced inadequate response.

When to Test Testosterone Before Prescribing Tadalafil

The Endocrine Society's 2018 clinical practice guideline recommends measuring morning total testosterone in all men presenting with sexual dysfunction. That guideline defines hypogonadism as a total testosterone below 300 ng/dL on two separate morning measurements, combined with symptoms.

If hypogonadism is identified, Oscar Health's coverage for testosterone replacement therapy (TRT) follows a separate formulary pathway. Tadalafil and TRT can be prescribed concurrently, and both should be documented in the PA packet if both are being requested.

Cardiovascular Screening Before Starting PDE5 Inhibitors

The Princeton III Consensus recommends cardiovascular risk stratification before initiating PDE5 inhibitor therapy. That consensus document classifies patients into low, intermediate, and high cardiovascular risk, with high-risk patients requiring cardiology clearance before PDE5 inhibitor prescribing. Documenting that cardiovascular screening was completed strengthens the medical necessity argument in any PA or appeal submission.

Lifestyle Factors That Affect Both ED and Insurance Coverage

A 2022 meta-analysis in JAMA Network Open found that aerobic exercise interventions reduced erectile dysfunction severity scores by a clinically meaningful margin in men with mild-to-moderate ED. Some Oscar plans with a wellness component offer incentives for documented lifestyle interventions, and documenting attempted lifestyle modification before requesting pharmacotherapy strengthens a medical necessity argument.

Key modifiable risk factors for ED include obesity (BMI above 30), cigarette smoking, sedentary lifestyle, uncontrolled type 2 diabetes, and hypertension. The CDC's national diabetes statistics report notes that approximately 37.3 million Americans live with diabetes, a population in which ED prevalence may reach 50 percent or higher compared with roughly 22 percent in the general adult male population.

Documenting these risk factors and any interventions attempted adds clinical depth to a PA request and shows Oscar's reviewers that the prescribing clinician followed a stepwise approach before requesting the medication.

Monitoring and Follow-Up After Starting Tadalafil

Once coverage is secured and tadalafil is initiated, clinical follow-up at 4 to 6 weeks is standard. The AUA erectile dysfunction guideline recommends reassessing efficacy using a validated tool such as the International Index of Erectile Function (IIEF-5), a five-question questionnaire scored 0 to 25. A score below 21 indicates some degree of erectile dysfunction.

Dose Adjustments and Reauthorization

If tadalafil 10 mg as-needed is inadequate, your provider may escalate to 20 mg. This dose change requires updating the prescription and potentially resubmitting a PA request if the original authorization was dose-specific. Document the inadequate response at 10 mg explicitly in the reauthorization packet.

Annual reauthorization is common for chronic daily tadalafil at 5 mg. Proactively submitting renewal documentation 30 days before the authorization expires prevents coverage gaps.